메뉴 건너뛰기




Volumn 68, Issue 12, 2008, Pages 4910-4918

Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptor

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; ESTROGEN; ESTROGEN RECEPTOR ALPHA; EXEMESTANE; LETROZOLE; TAMOXIFEN; AROMATASE; MESSENGER RNA;

EID: 49649111492     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-0303     Document Type: Article
Times cited : (90)

References (45)
  • 3
    • 0032031754 scopus 로고    scopus 로고
    • In situ aromatization enhances breast tumor estradiol levels and cellular proliferation
    • Yue W, Wang JP, Hamilton CJ, Demers LM, Santen RJ. In situ aromatization enhances breast tumor estradiol levels and cellular proliferation. Cancer Res 1998;58:927-32.
    • (1998) Cancer Res , vol.58 , pp. 927-932
    • Yue, W.1    Wang, J.P.2    Hamilton, C.J.3    Demers, L.M.4    Santen, R.J.5
  • 4
    • 0029890377 scopus 로고    scopus 로고
    • Molecular mechanisms of estrogen carcinogenesis
    • Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1996;36: 203-32.
    • (1996) Annu Rev Pharmacol Toxicol , vol.36 , pp. 203-232
    • Yager, J.D.1    Liehr, J.G.2
  • 5
    • 10744224293 scopus 로고    scopus 로고
    • Genotoxic metabolites of estradiol in breast: Potential mechanism of estradiol induced carcinogenesis
    • Yue W, Santen RJ, Wang JP, et al. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol 2003;86:477-86.
    • (2003) J Steroid Biochem Mol Biol , vol.86 , pp. 477-486
    • Yue, W.1    Santen, R.J.2    Wang, J.P.3
  • 6
    • 0032887942 scopus 로고    scopus 로고
    • Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer
    • Nicholson RI, McClelland RA, Robertson JF, Gee JM. Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer. Endocr Relat Cancer 1999;6:373-87.
    • (1999) Endocr Relat Cancer , vol.6 , pp. 373-387
    • Nicholson, R.I.1    McClelland, R.A.2    Robertson, J.F.3    Gee, J.M.4
  • 7
    • 30944469849 scopus 로고    scopus 로고
    • Estrogen carcinogenesis in breast cancer
    • Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354:270-82.
    • (2006) N Engl J Med , vol.354 , pp. 270-282
    • Yager, J.D.1    Davidson, N.E.2
  • 8
    • 30444434216 scopus 로고    scopus 로고
    • Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer
    • Jordan VC. Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer. Br J Pharmacol 2006;147 Suppl 1:S269-76.
    • (2006) Br J Pharmacol , vol.147 , Issue.SUPPL. 1
    • Jordan, V.C.1
  • 9
    • 12144269500 scopus 로고    scopus 로고
    • Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer
    • s
    • Osborne CK, Shou J, Massarweh S, Schiff R. Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clin Cancer Res 2005;11:865-70s.
    • (2005) Clin Cancer Res , vol.11 , pp. 865-870
    • Osborne, C.K.1    Shou, J.2    Massarweh, S.3    Schiff, R.4
  • 10
    • 11244296162 scopus 로고    scopus 로고
    • Mechanisms of tamoxifen resistance
    • Ring A, Dowsett M. Mechanisms of tamoxifen resistance. Endocr Relat Cancer 2004;11:643-58.
    • (2004) Endocr Relat Cancer , vol.11 , pp. 643-658
    • Ring, A.1    Dowsett, M.2
  • 11
    • 10744223655 scopus 로고    scopus 로고
    • A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
    • Coombes RC, Hall E, Gibson LJ, et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004;350:1081-92.
    • (2004) N Engl J Med , vol.350 , pp. 1081-1092
    • Coombes, R.C.1    Hall, E.2    Gibson, L.J.3
  • 12
    • 24744450378 scopus 로고    scopus 로고
    • Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCIC CTG MA.17
    • Goss PE, Ingle JN, Martino S, et al. Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. J Natl Cancer Inst 2005; 97:1262-71.
    • (2005) J Natl Cancer Inst , vol.97 , pp. 1262-1271
    • Goss, P.E.1    Ingle, J.N.2    Martino, S.3
  • 13
    • 11444251764 scopus 로고    scopus 로고
    • Results of the ATAC(Arimid ex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer
    • Howell A, Cuzick J, Baum M, et al. Results of the ATAC(Arimid ex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 2005;365:60-2.
    • (2005) Lancet , vol.365 , pp. 60-62
    • Howell, A.1    Cuzick, J.2    Baum, M.3
  • 14
    • 0035464108 scopus 로고    scopus 로고
    • Aromatase, aromatase inhibitors, and breast cancer
    • Brueggemeier RW. Aromatase, aromatase inhibitors, and breast cancer. Am J Ther 2001;8:333-44.
    • (2001) Am J Ther , vol.8 , pp. 333-344
    • Brueggemeier, R.W.1
  • 15
    • 0019797751 scopus 로고
    • Isolation and characterization of a tamoxifen-resistant cell line derived from MCF-7 human breast cancer cells
    • Nawata H, Bronzert D, Lippman ME. Isolation and characterization of a tamoxifen-resistant cell line derived from MCF-7 human breast cancer cells. J Biol Chem 1981;256:5016-21.
    • (1981) J Biol Chem , vol.256 , pp. 5016-5021
    • Nawata, H.1    Bronzert, D.2    Lippman, M.E.3
  • 16
    • 0021333951 scopus 로고
    • Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells
    • Vignon F, Lippman ME, Nawata H, Derocq D, Rochefort H. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells. Cancer Res 1984;44:2084-8.
    • (1984) Cancer Res , vol.44 , pp. 2084-2088
    • Vignon, F.1    Lippman, M.E.2    Nawata, H.3    Derocq, D.4    Rochefort, H.5
  • 17
    • 17844398046 scopus 로고    scopus 로고
    • Molecular changes in tamoxifen-resistant breast cancer: Relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase
    • Gutierrez MC, Detre S, Johnston S, et al. Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase. J Clin Oncol 2005;23: 2469-76.
    • (2005) J Clin Oncol , vol.23 , pp. 2469-2476
    • Gutierrez, M.C.1    Detre, S.2    Johnston, S.3
  • 18
    • 33745402375 scopus 로고    scopus 로고
    • Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells
    • Epub Dec 7
    • Hiscox S, Morgan L, Green TP, Barrow D, Gee J, Nicholson RI. Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells. Breast Cancer Res Treat 2006;97:263-74. Epub 2005 Dec 7.
    • (2005) Breast Cancer Res Treat 2006 , vol.97 , pp. 263-274
    • Hiscox, S.1    Morgan, L.2    Green, T.P.3    Barrow, D.4    Gee, J.5    Nicholson, R.I.6
  • 20
    • 18844427567 scopus 로고    scopus 로고
    • Upregulation of PKC-δ contributes to antiestrogen resistance in mammary tumor cells
    • Nabha SM, Glaros S, Hong M, et al. Upregulation of PKC-δ contributes to antiestrogen resistance in mammary tumor cells. Oncogene 2005;24:3166-76.
    • (2005) Oncogene , vol.24 , pp. 3166-3176
    • Nabha, S.M.1    Glaros, S.2    Hong, M.3
  • 22
    • 2942652871 scopus 로고    scopus 로고
    • Mechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer
    • Shou J, Massarweh S, Osborne CK, et al. Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. J Natl Cancer Inst 2004;96:926-35.
    • (2004) J Natl Cancer Inst , vol.96 , pp. 926-935
    • Shou, J.1    Massarweh, S.2    Osborne, C.K.3
  • 23
    • 0042232592 scopus 로고    scopus 로고
    • Enhanced estrogen receptor (ER) α, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation
    • Martin LA, Farmer I, Johnston SR, Ali S, Marshall C, Dowsett M. Enhanced estrogen receptor (ER) α, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation. J Biol Chem 2003;278:30458-68.
    • (2003) J Biol Chem , vol.278 , pp. 30458-30468
    • Martin, L.A.1    Farmer, I.2    Johnston, S.R.3    Ali, S.4    Marshall, C.5    Dowsett, M.6
  • 24
    • 18144387234 scopus 로고    scopus 로고
    • The role of growth factor receptor pathways in human breast cancer cells adapted to long-term estrogen deprivation
    • Sabnis GJ, Jelovac D, Long B, Brodie A. The role of growth factor receptor pathways in human breast cancer cells adapted to long-term estrogen deprivation. Cancer Res 2005;65:3903-10.
    • (2005) Cancer Res , vol.65 , pp. 3903-3910
    • Sabnis, G.J.1    Jelovac, D.2    Long, B.3    Brodie, A.4
  • 25
    • 25844459070 scopus 로고    scopus 로고
    • Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity
    • Santen RJ, Song RX, Zhang Z, et al. Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity. Endocr Relat Cancer 2005;12 Suppl 1:S61-73.
    • (2005) Endocr Relat Cancer , vol.12 , Issue.SUPPL. 1
    • Santen, R.J.1    Song, R.X.2    Zhang, Z.3
  • 26
    • 20644465808 scopus 로고    scopus 로고
    • Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole
    • Jelovac D, Sabnis G, Long BJ, Macedo L, Goloubeva OG, Brodie AM. Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole. Cancer Res 2005;65:5380-9.
    • (2005) Cancer Res , vol.65 , pp. 5380-5389
    • Jelovac, D.1    Sabnis, G.2    Long, B.J.3    Macedo, L.4    Goloubeva, O.G.5    Brodie, A.M.6
  • 27
    • 0031458548 scopus 로고    scopus 로고
    • Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D cells
    • Sun XZ, Zhou D, Chen S. Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D cells. J Steroid Biochem Mol Biol 1997;63: 29-36.
    • (1997) J Steroid Biochem Mol Biol , vol.63 , pp. 29-36
    • Sun, X.Z.1    Zhou, D.2    Chen, S.3
  • 28
    • 0017184389 scopus 로고
    • A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
    • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
    • (1976) Anal Biochem , vol.72 , pp. 248-254
    • Bradford, M.M.1
  • 29
    • 17144420079 scopus 로고    scopus 로고
    • Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: A microarray approach
    • Itoh T, Karlsberg K, Kijima I, et al. Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approach. Mol Cancer Res 2005;3:203-18.
    • (2005) Mol Cancer Res , vol.3 , pp. 203-218
    • Itoh, T.1    Karlsberg, K.2    Kijima, I.3
  • 30
    • 27744543104 scopus 로고    scopus 로고
    • Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen
    • Kijima I, Itoh T, Chen S. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen. J Steroid Biochem Mol Biol 2005;97:360-8.
    • (2005) J Steroid Biochem Mol Biol , vol.97 , pp. 360-368
    • Kijima, I.1    Itoh, T.2    Chen, S.3
  • 31
    • 33751275796 scopus 로고    scopus 로고
    • Aromatase destabilizer: Novel action of exemestane, a food and drug administration-approved aromatase inhibitor
    • Wang X, Chen S. Aromatase destabilizer: novel action of exemestane, a food and drug administration-approved aromatase inhibitor. Cancer Res 2006;66:10281-6.
    • (2006) Cancer Res , vol.66 , pp. 10281-10286
    • Wang, X.1    Chen, S.2
  • 32
    • 23744443778 scopus 로고    scopus 로고
    • Adaptive hypersensitivity to estrogen: Mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment
    • Santen RJ, Song RX, Zhang Z, et al. Adaptive hypersensitivity to estrogen: mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment. J Steroid Biochem Mol Biol 2005;95: 155-65.
    • (2005) J Steroid Biochem Mol Biol , vol.95 , pp. 155-165
    • Santen, R.J.1    Song, R.X.2    Zhang, Z.3
  • 33
    • 54749125642 scopus 로고    scopus 로고
    • Characterization of the weak ERα agonistic activity of exemestane [abstract 5434]
    • Masri S, Lui K, Phung S, et al. Characterization of the weak ERα agonistic activity of exemestane [abstract 5434]. Proc Am Assoc Cancer Res 2008;49:1291.
    • (2008) Proc Am Assoc Cancer Res , vol.49 , pp. 1291
    • Masri, S.1    Lui, K.2    Phung, S.3
  • 34
    • 42049120692 scopus 로고    scopus 로고
    • The role of amphiregulin in exemestane-resistant breast cancer cells: Evidence of an autocrine loop
    • Wang X, Masri S, Phung S, Chen S. The role of amphiregulin in exemestane-resistant breast cancer cells: evidence of an autocrine loop. Cancer Res 2008;68: 2259-65.
    • (2008) Cancer Res , vol.68 , pp. 2259-2265
    • Wang, X.1    Masri, S.2    Phung, S.3    Chen, S.4
  • 35
    • 38849091433 scopus 로고    scopus 로고
    • Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function
    • Massarweh S, Osborne CK, Creighton CJ, et al. Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function. Cancer Res 2008;68:826-33.
    • (2008) Cancer Res , vol.68 , pp. 826-833
    • Massarweh, S.1    Osborne, C.K.2    Creighton, C.J.3
  • 36
    • 4644243456 scopus 로고    scopus 로고
    • Tamoxifen long-term treatment in vitro alters the apoptotic response of MCF-7 breast cancer cells
    • Treeck O, Zhou R, Diedrich K, Ortmann O. Tamoxifen long-term treatment in vitro alters the apoptotic response of MCF-7 breast cancer cells. Anticancer Drugs 2004;15:787-93.
    • (2004) Anticancer Drugs , vol.15 , pp. 787-793
    • Treeck, O.1    Zhou, R.2    Diedrich, K.3    Ortmann, O.4
  • 37
    • 28744431757 scopus 로고    scopus 로고
    • Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: Implicated role of growth factor signaling and estrogen receptor coregulators
    • Schiff R, Massarweh SA, Shou J, et al. Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators. Cancer Chemother Pharmacol 2005;56 Suppl 1:10-20.
    • (2005) Cancer Chemother Pharmacol , vol.56 , Issue.SUPPL. 1 , pp. 10-20
    • Schiff, R.1    Massarweh, S.A.2    Shou, J.3
  • 38
    • 34548445351 scopus 로고    scopus 로고
    • Molecular response to aromatase inhibitor treatment in primary breast cancer
    • Mackay A, Urruticoechea A, Dixon JM, et al. Molecular response to aromatase inhibitor treatment in primary breast cancer. Breast Cancer Res 2007;9:R37.
    • (2007) Breast Cancer Res , vol.9
    • Mackay, A.1    Urruticoechea, A.2    Dixon, J.M.3
  • 39
    • 24744443547 scopus 로고    scopus 로고
    • Estrogen receptor-positive, progesterone receptor-negative breast cancer: Association with growth factor receptor expression and tamoxifen resistance
    • Arpino G, Weiss H, Lee AV, et al. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. J Natl Cancer Inst 2005;97:1254-61.
    • (2005) J Natl Cancer Inst , vol.97 , pp. 1254-1261
    • Arpino, G.1    Weiss, H.2    Lee, A.V.3
  • 40
    • 32944482243 scopus 로고    scopus 로고
    • Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy
    • Cui X, Schiff R, Arpino G, Osborne CK, Lee AV. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. J Clin Oncol 2005;23:7721-35.
    • (2005) J Clin Oncol , vol.23 , pp. 7721-7735
    • Cui, X.1    Schiff, R.2    Arpino, G.3    Osborne, C.K.4    Lee, A.V.5
  • 41
    • 33645234316 scopus 로고    scopus 로고
    • Bidirectional cross talk between ERa and EGFR signalling pathways regulates tamoxifen-resistant growth
    • Britton DJ, Hutcheson IR, Knowlden JM, et al. Bidirectional cross talk between ERa and EGFR signalling pathways regulates tamoxifen-resistant growth. Breast Cancer Res Treat 2006;96:131-46.
    • (2006) Breast Cancer Res Treat , vol.96 , pp. 131-146
    • Britton, D.J.1    Hutcheson, I.R.2    Knowlden, J.M.3
  • 42
    • 33846827373 scopus 로고    scopus 로고
    • Endocrine therapy resistance can be associated with high estrogen receptor α (ERα) expression and reduced ERα phosphorylation in breast cancer models
    • Kuske B, Naughton C, Moore K, et al. Endocrine therapy resistance can be associated with high estrogen receptor α (ERα) expression and reduced ERα phosphorylation in breast cancer models. Endocr Relat Cancer 2006;13:1121-33.
    • (2006) Endocr Relat Cancer , vol.13 , pp. 1121-1133
    • Kuske, B.1    Naughton, C.2    Moore, K.3
  • 43
    • 0035971181 scopus 로고    scopus 로고
    • Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α: A new model for anti-estrogen resistance
    • Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S, Nakshatri H. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α: a new model for anti-estrogen resistance. J Biol Chem 2001;276:9817-24.
    • (2001) J Biol Chem , vol.276 , pp. 9817-9824
    • Campbell, R.A.1    Bhat-Nakshatri, P.2    Patel, N.M.3    Constantinidou, D.4    Ali, S.5    Nakshatri, H.6
  • 44
    • 0029877913 scopus 로고    scopus 로고
    • Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
    • Bunone G, Briand PA, Miksicek RJ, Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 1996;15:2174-83.
    • (1996) EMBO J , vol.15 , pp. 2174-2183
    • Bunone, G.1    Briand, P.A.2    Miksicek, R.J.3    Picard, D.4
  • 45
    • 0028886694 scopus 로고
    • Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
    • Kato S, Endoh H, Masuhiro Y, et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995;270:1491-4.
    • (1995) Science , vol.270 , pp. 1491-1494
    • Kato, S.1    Endoh, H.2    Masuhiro, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.